Signet Jewelers (NYSE:SIG) +29% on Q2 results.
Edesa Biotech (NASDAQ:EDSA) +19% on study of EB02 for internal hemorrhoids.
Global Blood Therapeutics (NASDAQ:GBT) +15% as FDA accepts Global Blood's application for voxelotor for SCD.
Eltek (NASDAQ:ELTK) +15%.
Cloudera (NYSE:CLDR) +12% on Q2 results and analyst upgrade.
Bridgeline Digital (NASDAQ:BLIN) +11% as global-100 manufacturer selects the company to manage content for their salesforce lightning community with Bridgeline’s orchestraCMS platform.
Palo Alto Networks (NYSE:PANW) +9% on Q4 results.
Equinor ASA (NYSE:EQNR) +8% on stock buyback, confirms early Sverdrup start-up.
Tata Motors (NYSE:TTM) +6%.
G-III Apparel (NASDAQ:GIII) +6% on Q2 results.
Lands' End (NASDAQ:LE) +6% on Q2 results.